« Back
Home /
Sofosbuvir α-Isomer

Sofosbuvir α-Isomer

Manufacturer	Toronto Research Chemicals
Category	Neuroscience Molecular Targets for Neuroscience Reagents & Chemicals Other Chemicals
Type	Biochemicals
Specific against	other
Amount	10mg
Item no.	TRC-S675650-10mg
eClass 6.1	32160405
eClass 9.0	32160490
Available
Mol. Formula	C22H29FN3O9P
Mol. Weight	529, 45
Appearance	No Data Available
Application Notes	Sofosbuvir alpha-Isomer is a derivative compound of Sofosbuvir (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.
Melting Pt.	No Data Available
Boiling Pt.	No Data Available
Solubility	No Data Available
Stability	No Data Available
Storage Condition	No Data Available

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

available

Delivery expected until 6/6/2024